Pathway Specific Targeting in Anticancer Therapies Writer and Curator: Larry H. Bernstein, MD, FCAP    7.7 Pathway specific targeting in anticancer therapies 7.7.1 Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism 7.7.2 Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via … Continue reading Pathway Specific Targeting in Anticancer Therapies [7.7]